U.S. Rep. Jennifer Wexton on Monday announced she won’t seek reelection to Congress after doctors discovered she suffers from a rare neurological disorder that was previously misdiagnosed as Parkinson’s Disease.
The majority of rare diseases currently have no or few effective diagnostic and treatment procedures, which can be attributed in part to a lack of funding for research on rare disease pathogenesis and a lack of representative patients. Rare Neurological Disease Treatment Market are one of the most common types of ra.
According to a recent report by Future Market Insights, the market for treating rare neurological diseases will experience phenomenal growth between 2022 and 2032. By the end of 2032, revenues from the treatment of rare neurological disorders are expected to surpass US$ 19.795.14 million.According to a newly publish.
- Following treatment, the N-acetylaspartate levels of CANaspire participants are consistent with levels seen in individuals with milder Canavan disease based on findings from the Company’s. | May 22, 2023
/PRNewswire/ The "Rare Neurological Disease Treatment Market - Growth, Trends, and Forecasts (2023-2028)" report has been added to ResearchAndMarkets.com s.